Search Results - "Forlani, Angelo"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
  2. 2
  3. 3

    Gene expression profiling of melanocortin system in neuropathic rats supports a role in nociception by Beltramo, Massimiliano, Campanella, Marilena, Tarozzo, Glauco, Fredduzzi, Silva, Corradini, Laura, Forlani, Angelo, Bertorelli, Rosalia, Reggiani, Angelo

    Published in Brain research. Molecular brain research. (21-10-2003)
    “…The melanocortin (MC) system is involved in several biological functions. Its possible role in nociception has recently attracted attention in the field…”
    Get full text
    Journal Article
  4. 4

    Lack of the nociceptin receptor does not affect acute or chronic nociception in mice by Bertorelli, Rosalia, Bastia, Elena, Citterio, Francesca, Corradini, Laura, Forlani, Angelo, Ongini, Ennio

    Published in Peptides (New York, N.Y. : 1980) (01-09-2002)
    “…The peptide nociceptin/orphanin FQ (N/OFQ) and its receptor ORL-1, also designated opioid receptor 4 (OP 4) are involved in the modulation of nociception…”
    Get full text
    Journal Article
  5. 5
  6. 6

    HEMODYNAMIC CHANGES DO NOT MEDIATE THE CARDIOPROTECTION INDUCED BY THE A1, ADENOSINE RECEPTOR AGONIST CCPA IN THE RABBIT by CASATI, CARLO, FORLANI, ANGELO, LOZZA, GIANLUCA, MONOPOLI, ANGELA

    Published in Pharmacological research (01-01-1997)
    “…Stimulation of adenosine A1receptors is known to reduce infarct size in the rabbit heart. The aim of the present study was to verify whether a protective…”
    Get full text
    Journal Article
  7. 7

    Blockade of adenosine A2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats by Monopoli, Angela, Lozza, Gianluca, Forlani, Angelo, Mattavelli, Amanda, Ongini, Ennio

    Published in Neuroreport (01-12-1998)
    “…BLOCKADE of adenosine receptors can reduce cerebral infarct size in the model of global ischaemia. Using the potent and selective A2A adenosine receptor…”
    Get full text
    Journal Article
  8. 8

    Cardiovascular pharmacology of the A2A adenosine receptor antagonist, SCH 58261, in the rat by Monopoli, A, Casati, C, Lozza, G, Forlani, A, Ongini, E

    “…We characterized the in vivo cardiovascular profile of SCH 58261, 7-(2-phenylethyl)-5-amino-2-(2-furyl)-pyrazolo-[4,3-e]-1,2, 4-triazolo[1,5-c] pyrimidine, a…”
    Get more information
    Journal Article
  9. 9

    Mechanism and Pressor Relevance of the Short-Term Cardiovascular and Renin Excitatory Actions of the Selective A2A-Adenosine Receptor Agonists by Alberti, Cristina, Monopoli, Angela, Casati, Carlo, Forlani, Angelo, Sala, Carla, Nador, Barbara, Ongini, Ennio, Morganti, Alberto

    Published in Journal of cardiovascular pharmacology (01-09-1997)
    “…Selective A2A adenosine receptor agonists are potent vasodilators that reduce blood pressure and induce marked increments in heart rate and plasma renin…”
    Get full text
    Journal Article
  10. 10

    5-Hydroxytryptamine induces contraction in isolated human mammary artery: effect of ketanserin by Monopoli, A, Conti, A, Forlani, A, Ongini, E, Antona, C, Biglioli, P

    Published in Cardiovascular drugs and therapy (01-01-1990)
    “…5-hydroxytryptamine (5HT) treatment produced dose-related contractions in the human internal mammary artery with an EC50 value of 3.4 X 10(-7) M. The 5HT2…”
    Get full text
    Journal Article